Multiple Sclerosis International Federation

 
 
News
Donate advanced search
print version print this page
 

inside
News:

 

  FDA Agrees to fast review for oral drug being tested for MS
It was announced by the drug makers Teva Pharmaceutical Industries and Active Biotech that oral laquinimod has been designated by the US Food and Drug Administration as a "Fast Track Product."

To read more, as reported by the US National MS Society,
click here.


Source: US National MS Society

Copyright &<br>Link Policy Copyright &
Link Policy
Privacy Policy Privacy Policy back to top
Disclaimer Disclaimer Acknowledgements Acknowledgements
back to top  back to top  
Email Update Email Update Edit User Details Edit User Details Feedback Feedback Glossary Glossary Site Map Site Map
Back to top Back to top